These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 37682196)
1. Identification of a new anoikis-related gene signature for prognostic significance in head and neck squamous carcinomas. Wei Z; Zhou C; Shen Y; Deng H; Shen Z Medicine (Baltimore); 2023 Sep; 102(36):e34790. PubMed ID: 37682196 [TBL] [Abstract][Full Text] [Related]
2. Predicting the prognosis, immune response, and immunotherapy in head and neck squamous cell carcinoma using a novel risk model based on anoikis-related lncRNAs. Deng H; Wei Z; Du J; Shen Z; Zhou C Eur J Med Res; 2023 Nov; 28(1):548. PubMed ID: 38017579 [TBL] [Abstract][Full Text] [Related]
3. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma. Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376 [TBL] [Abstract][Full Text] [Related]
4. Development of Chromatin Regulator-related Molecular Subtypes and a Signature to Predict Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma. Huang J; Xu Z; Wang Z; Zhou C; Shen Y Curr Cancer Drug Targets; 2024; 24(8):804-819. PubMed ID: 38310463 [TBL] [Abstract][Full Text] [Related]
5. ANXA5 predicts prognosis and immune response and mediates proliferation and migration in head and neck squamous cell carcinoma. Yang D; Chen H; Zhou Z; Guo J Gene; 2024 Dec; 931():148867. PubMed ID: 39168258 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive bioinformatics analysis and experimental validation: An anoikis-related gene prognostic model for targeted drug development in head and neck squamous cell carcinoma. Qiu L; Tao A; Sun X; Liu F; Ge X; Li C Oncol Res; 2023; 31(5):715-752. PubMed ID: 37547764 [TBL] [Abstract][Full Text] [Related]
8. Construction of an m6A-related lncRNA pair prognostic signature and prediction of the immune landscape in head and neck squamous cell carcinoma. Zhou C; Wang S; Shen Z; Shen Y; Li Q; Shen Y; Huang J; Deng H; Ye D; Zhan G; Li J J Clin Lab Anal; 2022 Jan; 36(1):e24113. PubMed ID: 34783061 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma. He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150 [TBL] [Abstract][Full Text] [Related]
10. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
11. An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: Prognostic assessment and treatment guidance. Han Y; Shi Y; Chen B; Wang J; Liu Y; Sheng S; Fu Z; Shen C; Wang X; Yin S; Li H Front Immunol; 2022; 13():961695. PubMed ID: 36389709 [TBL] [Abstract][Full Text] [Related]
12. Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma. He Z; Gu Y; Yang H; Fu Q; Zhao M; Xie Y; Liu Y; Du W J Cancer Res Clin Oncol; 2023 Oct; 149(13):11661-11678. PubMed ID: 37402968 [TBL] [Abstract][Full Text] [Related]
13. Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma. Huang J; Xu Z; Teh BM; Zhou C; Yuan Z; Shi Y; Shen Y J Clin Lab Anal; 2022 Jun; 36(6):e24480. PubMed ID: 35522142 [TBL] [Abstract][Full Text] [Related]
14. Identification of a metabolic reprogramming-related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis. Qiang W; Dai Y; Xing X; Sun X Cancer Med; 2022 Aug; 11(16):3168-3181. PubMed ID: 35301800 [TBL] [Abstract][Full Text] [Related]
15. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients. Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X Front Immunol; 2022; 13():1100417. PubMed ID: 36703967 [TBL] [Abstract][Full Text] [Related]
16. An angiogenesis-associated gene-based signature predicting prognosis and immunotherapy efficacy of head and neck squamous cell carcinoma patients. Chen B; Han Y; Sheng S; Deng J; Vasquez E; Yau V; Meng M; Sun C; Wang T; Wang Y; Sheng M; Wu T; Wang X; Liu Y; Lin N; Zhang L; Shao W J Cancer Res Clin Oncol; 2024 Feb; 150(2):91. PubMed ID: 38347320 [TBL] [Abstract][Full Text] [Related]
17. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC. Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648 [TBL] [Abstract][Full Text] [Related]
18. A Signature of N Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X Front Immunol; 2022; 13():809872. PubMed ID: 35185897 [TBL] [Abstract][Full Text] [Related]
19. Identification of several senescence-associated genes signature in head and neck squamous cell carcinoma. Wang J; Zhou CC; Sun HC; Li Q; Hu JD; Jiang T; Zhou S J Clin Lab Anal; 2022 Jul; 36(7):e24555. PubMed ID: 35692082 [TBL] [Abstract][Full Text] [Related]
20. Anoikis-related genes in breast cancer patients: reliable biomarker of prognosis. Tang M; Rong Y; Li X; Pan H; Tao P; Wu Z; Liu S; Tang R; Liu Z; Cai H BMC Cancer; 2024 Sep; 24(1):1163. PubMed ID: 39300389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]